BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Daw MA, El-Bouzedi AA, Ahmed MO, Dau AA, Agnan MM, Drah AM. Geographic integration of hepatitis C virus: A global threat. World J Virol 2016; 5(4): 170-182 [PMID: 27878104 DOI: 10.5501/wjv.v5.i4.170]
URL: https://www.wjgnet.com/2220-3249/full/v5/i4/170.htm
Number Citing Articles
1
Marina Barriocanal, Puri Fortes. Long Non-coding RNAs in Hepatitis C Virus-Infected CellsFrontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.01833
2
Luis Antonio Uribe‐Noguez, Alicia Ocaña‐Mondragón, José Antonio Mata‐Marín, María Elena Gómez‐Torres, Rosa María Ribas‐Aparicio, María de la Luz Martínez‐Rodríguez. Presence of rare hepatitis C virus subtypes, 2j, 2k, and 2r in Mexico City as identified by sequencingJournal of Medical Virology 2018; 90(7): 1277 doi: 10.1002/jmv.25070
3
Yelena Petrosyan, John-Graydon Simmons, Erin Kelly, Curtis L Cooper. Uptake and factors associated with direct-acting antiviral therapy for hepatitis C and treatment outcomes among Canadian immigrants: A retrospective cohort analysisCanadian Liver Journal 2022; 5(3): 388 doi: 10.3138/canlivj-2021-0037
4
T. Semenova, B. Nemoz, V. Thibault, G. Lagathu, G. Duverlie, E. Brochot, P. Trimoulet, C. Payan, S. Vallet, C. Henquell, S. Chevaliez, M. Bouvier-Alias, S. Maylin, A-M. Roque-Afonso, L. Izquierdo, F. Lunel-Fabiani, P. Marcellin, P. Morand, V. Leroy, S. Larrat. Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP studyEpidemiology and Infection 2019; 147 doi: 10.1017/S0950268819001225
5
Mohamed Ali Daw, Amina Mohamed Daw, Nadia Emhemed Mohamed Sifennasr, Aisha Draha, Ahmed Daw, Ali Daw, Mohamed Ahmed, Ebtisam Mokhtar, Abdallah El-Bouzedi, Ibrahem Daw, Samia Adam, Saed Warrag. The epidemiological characterization and geographic distribution of hepatitis D virus infection in LibyaPan African Medical Journal 2020; 35 doi: 10.11604/pamj.2020.35.120.20055
6
Mohamed A. Daw, Lutfi A. Buktir Ali, Amina M. Daw, Nadia E. M. Sifennasr, Aghnyia A. Dau, Mohamed M. Agnan, Abdallah El-Bouzedi. The geographic variation and spatiotemporal distribution of hepatitis C virus infection in Libya: 2007–2016BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3471-4
7
Mingyang Li, Hui Zhuang, Lai Wei. How would China achieve WHO’s target of eliminating HCV by 2030?Expert Review of Anti-infective Therapy 2019; 17(10): 763 doi: 10.1080/14787210.2019.1675509
8
Anna D. Kashnikova, Tatiana N. Bystrova, Anastasia V. Polyanina, Artem A. Zalesskikh. Genetic Monitoring as a Component of Hepatitis C SurveillanceЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT 2022; : 76 doi: 10.35627/2219-5238/2022-30-11-76-81
9
Masoud Behzadifar, Hasan Abolghasem Gorji, Aziz Rezapour, Nicola Luigi Bragazzi. The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon’s multiple streams frameworkHealth Research Policy and Systems 2019; 17(1) doi: 10.1186/s12961-019-0436-z
10
Mohamed A. Daw, Nadia E.M. Sifennasr, Abdallah El-Bouzedi, Ali O. Daeke, Aghnyia A. Dau, Aisha M. Drah, Mohamed O. Ahmed, Mohamed M. Agnan. Epidemiology of hepatitis B virus in immigrants crossing to Europe from North and Sub-Saharan AfricaTravel Medicine and Infectious Disease 2017; 16: 59 doi: 10.1016/j.tmaid.2017.01.006
11
Jing Lu, Li Zhang, Xiaoqin Xu, Yuanfang Chen, Ying Zhou, Zhi Zhang, Gengfeng Fu, Guohong Chen. Hepatitis C virus genotype diversity and distribution among methadone maintenance treatment patients in Jiangsu, ChinaDrug and Alcohol Dependence 2019; 194: 101 doi: 10.1016/j.drugalcdep.2018.09.026
12
Christian Heuss, Paul Rothhaar, Rani Burm, Ji-Young Lee, Philipp Ralfs, Uta Haselmann, Luisa J. Ströh, Ombretta Colasanti, Cong Si Tran, Noemi Schäfer, Paul Schnitzler, Uta Merle, Ralf Bartenschlager, Arvind H. Patel, Frederik Graw, Thomas Krey, Vibor Laketa, Philip Meuleman, Volker Lohmann, Charles M. Rice. A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivoPLOS Pathogens 2022; 18(6): e1010472 doi: 10.1371/journal.ppat.1010472
13
Mohamed A. Daw, Abdallah El-Bouzedi, Mohamed O. Ahmed, Aghnyia A. Dau. Molecular and epidemiological characterization of HIV-1 subtypes among Libyan patientsBMC Research Notes 2017; 10(1) doi: 10.1186/s13104-017-2491-2
14
M.A. Wahab, A. Shehta, M. Elshoubary, A.M. Yassen, M. Elmorshedi, T. Salah, A.M. Sultan, O. Fathy, W.R. Elsarraf, U. Shiha, K. Zalata, A.N. Elghawalby, M. Eldesoky, A. Monier, R. Said, A.M. Elsabagh, M. Ali, A. Kandeel, U. Abdalla, M. Aboelella, M. Elsadany, E.E. Abdel-Khalek, A. Marwan, F.M. ElMorsi, R. Adly. Living-Donor Liver Transplantation in Hepatitis C Virus Era: A Report of 500 Consecutive Cases in a Single CenterTransplantation Proceedings 2018; 50(5): 1396 doi: 10.1016/j.transproceed.2018.02.085
15
Lyudmila I. Nikolaeva, Alexander N. Belyavtsev, Nadezhda G. Shevchenko, Maya D. Stuchinskaya, Evgeniy I. Samokhvalov, Anna V. Dedova, Georgiy V. Sapronov, Nataliya S. Shastina, Victor V. Kuprianov. The analysis of immunoreactivity of individual B-cell epitopes of hepatitis C virus <i>(Flaviviridae: Hepacivirus: Hepatitis С virus)</i> NS4a antigenProblems of Virology 2022; 67(3): 237 doi: 10.36233/0507-4088-115
16
Ahmed Mohammed Gaballah, Marwa Mohammed Esawy. Comparison of 2 different antibody assay methods, Elecsys Anti-HCVII (Roche) and Vidas Anti-HCV (Biomerieux), for the detection of antibody to hepatitis C virus in EgyptDiagnostic Microbiology and Infectious Disease 2018; 92(2): 107 doi: 10.1016/j.diagmicrobio.2018.05.013
17
Sanaa Kamal. Liver Cancer in the Middle East2021; : 299 doi: 10.1007/978-3-030-78737-0_18
18
Nuran Karabulut, Sema Alacam, Ayfer Yolcu, Mustafa Onel, Ali Agacfidan. Distribution of Hepatitis C Virus Genotypes in Istanbul, TurkeyIndian Journal of Medical Microbiology 2018; 36(2): 192 doi: 10.4103/ijmm.IJMM_17_381
19
Mohamed A. Daw. The Epidemiology of Hepatitis C virus infection in African immigrants; bridging the gapsTravel Medicine and Infectious Disease 2019; 27: 130 doi: 10.1016/j.tmaid.2018.05.012
20
Mohamed A. Daw, Abdallah El-Bouzedi, Mohamed O. Ahmed, Aghnyia A. Dau, Mohamed M. Agnan. Epidemiology of hepatitis C virus and genotype distribution in immigrants crossing to Europe from North and sub-Saharan AfricaTravel Medicine and Infectious Disease 2016; 14(5): 517 doi: 10.1016/j.tmaid.2016.05.020
21
Ruijun Su, Li Dong, Yongxiang Wang, Renna Sa, Yafei Wang. Distribution of hepatitis C virus genotype and subtype between Mongolian and Han in Inner MongoliaMedicine 2022; 101(28): e29545 doi: 10.1097/MD.0000000000029545
22
Nagehan Didem Sarı, Sevim Baltalı, İstemi Serin. Evaluation of Hepatitis C in 20 Years: A Turkish ExperienceBagcilar Medical Bulletin 2023; 8(4): 363 doi: 10.4274/BMB.galenos.2023.2023-01-07
23
Manousos E. Kambouris, Yiannis Manoussopoulos, Aristea Velegraki. Genomics in Biosecurity2022; : 61 doi: 10.1016/B978-0-323-85236-4.00013-3
24
Jin Yang, Yunquan Zhang, Lisha Luo, Runtang Meng, Chuanhua Yu. Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990–2016: An Age-Period-Cohort and Spatial Autocorrelation AnalysisInternational Journal of Environmental Research and Public Health 2018; 15(1): 170 doi: 10.3390/ijerph15010170